Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

A rare case linked complete hair loss to both pancreas and gallbladder cancer.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

The combination of encorafenib and binimetinib caused few skin issues.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Imuvert can prevent some chemotherapy-induced hair loss.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Vismodegib is effective for basal cell carcinoma but has severe side effects.